Regulus Therapeutics Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Carlsbad CA United States (2007)

Organization Overview

First Clinical Trial
2016
NCT02855268
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Regulus Therapeutics | Regulus Therapeutics Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

rg-012 (2 trials)

Drugs in Phase 1 Trials (2)

rgls4326 (1 trial)

rgls8429 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthrogryposis (Phase 1)

Kidney Diseases (Phase 1)

Nephritis, Hereditary (Phase 2)

Polycystic Kidney, Autosomal Dominant (Phase 1)

Polycystic Kidney Diseases (Phase 1)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3